Yongsheng Wang Selected Research

Yongsheng Wang Research Topics

Disease

104	Neoplasms (Cancer) 04/2024 - 02/2008
48	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 05/2010
44	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2005
32	Neoplasm Metastasis (Metastasis) 04/2024 - 04/2008
21	Adenocarcinoma of Lung 02/2024 - 08/2012
19	Lung Neoplasms (Lung Cancer) 12/2022 - 03/2009
13	Inflammation (Inflammations) 04/2023 - 01/2009
7	Triple Negative Breast Neoplasms 04/2024 - 09/2019
7	Carcinoma (Carcinomatosis) 01/2024 - 01/2009
7	Disease Progression 12/2023 - 08/2012
7	Infections 10/2023 - 07/2013
7	Carcinogenesis 01/2017 - 01/2013
6	Malignant Pleural Effusion 02/2024 - 05/2010
6	Hypoxia (Hypoxemia) 12/2023 - 01/2014
6	Stomach Neoplasms (Stomach Cancer) 10/2022 - 12/2011
4	Residual Neoplasm 04/2024 - 04/2013
4	Neutropenia 12/2022 - 01/2020
4	Liver Neoplasms (Liver Cancer) 09/2022 - 11/2013
4	Lymphatic Metastasis 01/2022 - 03/2005
4	Pathologic Complete Response 01/2021 - 12/2018
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 09/2009
3	Adenocarcinoma 01/2024 - 01/2017
3	Hypertension (High Blood Pressure) 01/2023 - 01/2020
3	Edema (Dropsy) 01/2023 - 06/2019
3	Ischemic Stroke 03/2022 - 08/2018
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 11/2020
3	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 04/2008
3	Radiation Pneumonitis 06/2020 - 01/2019
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 06/2015
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2016
3	Mastitis 04/2014 - 01/2013
2	Diarrhea 03/2024 - 12/2022
2	Pain (Aches) 02/2024 - 11/2015
2	Migraine Disorders (Migraine) 02/2024 - 07/2022
2	Exanthema (Rash) 12/2023 - 10/2022
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2023 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 02/2016

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2008
16	ErbB Receptors (EGF Receptor)IBA 04/2024 - 01/2012
15	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2014
12	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
8	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2011
8	MicroRNAs (MicroRNA)IBA 08/2021 - 04/2013
8	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 01/2011
7	Chimeric Antigen ReceptorsIBA 09/2023 - 12/2012
7	CytokinesIBA 01/2023 - 04/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 05/2010
7	Long Noncoding RNAIBA 08/2021 - 01/2015
7	Small Interfering RNA (siRNA)IBA 01/2017 - 01/2009
6	Immune Checkpoint InhibitorsIBA 04/2024 - 11/2020
6	Trastuzumab (Herceptin)FDA Link 10/2023 - 07/2015
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 05/2013
5	PlatinumIBA 04/2024 - 05/2013
5	Phosphotransferases (Kinase)IBA 01/2024 - 05/2014
5	AntigensIBA 01/2024 - 12/2012
5	Docetaxel (Taxotere)FDA Link 10/2023 - 05/2013
5	Gefitinib (Iressa)FDA Link 01/2021 - 03/2013
4	Anaplastic Lymphoma KinaseIBA 09/2023 - 10/2019
4	Capecitabine (Xeloda)FDA Link 01/2023 - 11/2016
4	LigandsIBA 01/2023 - 08/2013
4	Hormones (Hormone)IBA 01/2023 - 05/2019
4	Peptides (Polypeptides)IBA 03/2022 - 07/2010
4	Epirubicin (Ellence)FDA LinkGeneric 01/2022 - 07/2015
4	Pemetrexed (MTA)FDA Link 07/2021 - 01/2020
4	Messenger RNA (mRNA)IBA 11/2020 - 12/2007
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 01/2009
4	Liposomes (Liposome)IBA 07/2010 - 01/2009
3	N-acetyltalosaminuronic acid (NAT)IBA 04/2024 - 01/2021
3	Bevacizumab (Avastin)FDA Link 02/2024 - 04/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 07/2010
3	camrelizumabIBA 12/2023 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 05/2011
3	CateninsIBA 01/2023 - 06/2012
3	VaccinesIBA 01/2023 - 02/2008
3	Monoclonal AntibodiesIBA 01/2023 - 07/2022
3	Gemcitabine FDA Link 06/2022 - 03/2009
3	hetrombopagIBA 01/2022 - 11/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 09/2015
3	Inosine Triphosphate (ITP)IBA 01/2022 - 11/2020
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2016
3	Cancer VaccinesIBA 09/2020 - 09/2015
3	Taxoids (Taxanes)IBA 07/2020 - 11/2016
3	Cadherins (E-Cadherin)IBA 10/2018 - 06/2012
3	CollagenIBA 01/2017 - 01/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 11/2013
3	LipopolysaccharidesIBA 02/2016 - 12/2011
2	pertuzumabIBA 03/2024 - 01/2020
2	pyrotinibIBA 10/2023 - 12/2022
2	InflammasomesIBA 04/2023 - 01/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023 - 11/2017
2	osimertinibIBA 01/2023 - 01/2022

Therapy/Procedure

50	Therapeutics 04/2024 - 04/2008
25	Drug Therapy (Chemotherapy) 02/2024 - 08/2010
23	Radiotherapy 04/2024 - 03/2005
17	Immunotherapy 04/2024 - 04/2008
11	Neoadjuvant Therapy 04/2024 - 04/2015
3	Chemoradiotherapy 06/2020 - 12/2011
2	Lymph Node Excision (Lymph Node Dissection) 04/2024 - 01/2015
2	Punctures 12/2023 - 01/2016